- in Cancer Treatments
CASCINATION AG is an award-winning medical technology company from Bern (Switzerland) dedicated to the development, manufacturing and commercialization of innovations in computer-assisted and image-guided surgery. Our trailblazing navigation systems and surgical robots are designed to improve outcomes for patients undergoing surgical or interventional procedures and offer new perspectives to patients worldwide.
Our CAS-One planning and navigation system is used to treat patients suffering from soft tissue cancer (e.g., liver cancer) by many hospitals across Europe, and we are developing further applications in a number of disease areas. Our CAS-One planning and navigation system is CE marked and FDA cleared, and is used by many hospitals across the world. We are continually expanding our technology to new treatment areas where precision navigation can help to improve outcomes.
| 2020 | CE Mark for HEARO |
| 2019 | Winner Swiss Medtech Award with HEARO |
| 2017 | European Expansion |
| 2015 | FDA Clearance CAS-One IR |
| 2013 | Winner CTI Swiss Medtech Award with CAS-One IR |
| 2010 | CE Mark for CAS-One IR |
| 2009 | Company founded as spin-off from ARTORG Center, University of Bern |
Awards
| Winner Swiss Medtech Award | 2019 |
| Handelszeitung Wachstums-Champion (11th Rank) | 2017 |
| Finalist Swiss Economic Award | 2015 |
| Venture Kick Best Video Award | 2014 |
| Ypsomed InnovationspreisD | 2013 |
| Winner CTI Swiss Medtech Award | 2013 |
| Jungunternehmerpreis | 2011 |
| W.A. de Vigier Entrepreneurship Prize | 2011 |
| Finalist Swiss Technology Award | 2011 |
| CTI Start-up Label | 2010 |